Trinity Biotech (TRIB) reported Q4 EPS of ($0.23), versus $0.60 reported last year. Revenue for the quarter came in at $19.5 million versus the consensus estimate of $22 million.
Trinity Biotech (TRIB) reported Q4 EPS of ($0.23), versus $0.60 reported last year. Revenue for the quarter came in at $19.5 million versus the consensus estimate of $22 million.